期刊文献+

干细胞治疗慢性疼痛的研究进展

The research advances on stem cell for chronic pain management
原文传递
导出
摘要 背景动物实验研究证实,干细胞移植可以治疗多种神经退行性疾病和缺血性脑卒中。近年研究发现,其对慢性顽固性疼痛也有很好的治疗效果。目的综述干细胞移植对各种慢性顽固性疼痛的治疗作用及其机制。内容干细胞可应用于外周神经损伤导致的神经病理性疼痛(neuropathicpain,NP)、糖尿病周围神经痛、脊髓损伤(spinalcordinjury,SCI)后慢性疼痛以及下肢缺血性疼痛的治疗,主要机制是修复和免疫调节效应。趋向干细胞有望成为未来慢性顽固性疼痛治疗的重要手段。 Background Animal experiments have demonstrated that stem cell transplantation relieves various neurodegenerative diseases and ischemic stroke. Recent studies indicate that it may also be a therapeutic approach for intractable chronic pain management. Objective To review the application and potential mechanisms of stem cell transplantation for management of intractable chronic pain. Content Stem cell transplantation can be used for treatment of the neuropathic pain(NP) induced by peripheral nerve injury and diabetic peripheral neuropathy, and chronic pain involving spinal cord injury(SCI) and limb ischemia. Furthermore, the analgesic mechanisms include the repairing and immunomodulation properties. Trend Stem cell transplantation provides a new tool for the relief of intractable chronic pain.
出处 《国际麻醉学与复苏杂志》 CAS 2015年第10期945-949,共5页 International Journal of Anesthesiology and Resuscitation
基金 国家自然科学基金(81171055,81428008) 北京市卫生系统高层次卫生技术(人才学科骨干)培养计划 北京市自然科学基金(7152056)
关键词 疼痛 干细胞 慢性疼痛 Pain Stem cell Chronic pain
  • 相关文献

参考文献26

  • 1Wislet -Gendebien S. Wautier F, Leprince P, et al. Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin[J]. Brain Res Bull. 2005, 68 (J -2 ): 95 -102.
  • 2Gelati M, Profico 0, Projetti-Pensi M, et al. Culturing and expansion of "clinical grade" precursors cells from the fetal human central nervous system [J]. Methods Mol BioI, 2013, 1059: 65-77. DOl: 10.1007/978-1'f)2703-574-3_6.
  • 3Siniscalco 0, Giordano C, Galderisi U, et al Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice[J], Cell Mol Life Sci, 2010, 67(4): 655'f)69.
  • 4Siniscalco 0, Giordano C, Galderisi U, et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain?like behaviors, cellular, and biomolecular modifications in neuropathic mice[J]. Front Integr Neurosci, 2011, 5: 79. DOl: 10. 3389/fninI.2011.00079.
  • 5Franchi S, Valsecchi AE, Borsani E, et al. Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration inexperimental neuropathy [J]. Pain, 2012, 153(4): 850-861.
  • 6孙娇丽,田学愎,王鹏.神经调节蛋白1在慢性疼痛中的研究进展[J].国际麻醉学与复苏杂志,2013,34(3):269-272. 被引量:1
  • 7Cova L, Armentero MT, Zennaro E, et aL Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in anexperimental model of Parkinson's disease [J]. Brain Res, 2010, 1311: 12 -27. DOl: 10.1 0 16/j.brainres.2009. I 1. 041.
  • 8Xu Q, Zhang M, Liu J, et al. Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release ofGDNF[J]. Ann Clin Lab Sci, 2013,43(2): 154-162.
  • 9Butti E, Cusimano M, Bacigaluppi M, et aL Neurogenic and non?neurogenic functions of endogenous neural stem cells [J]. Front Neurosci, 2014, 8: 92. DOl: 1O.3389/fnins.2014.00092.
  • 10Sacerdote P, Niada S, Franchi S, et al. Systemic administration of human adipose -derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy [J]. Stem Cells Dev, 2013, 22( 8): 1252-1263.

二级参考文献19

  • 1Kanzaki H, Mizobuchi S, Obata N, et al. Expression changes of the neuregulin 1 isoforms in neuropathic pain model rats. Neurosci Lett, 2012, 508(2): 78-83.
  • 2Stei nthorsdottir V, Stefansson H, Ghosh S, et al. Multiple novel transcription initiation sites for NRG1. Gene, 2004, 342( 1 ) : 97-105.
  • 3Fricker FR, Laqo N, Balarajah S, et al. Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood. J Neurosci, 2011, 31(9): 3225-3233.
  • 4Calvo M, Zhu N, Tsantoulas C, et al. Neuregnlin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci, 2010, 30( 15 ) : 5437-5450.
  • 5Fricker FR, Zhu N, Tsantoulas C, et al. Sensory axon-derivedneuregulin-1 is required for axoglial signaling and normal sensory function but not for long-term axon maintenance. J Neurosci, 2009, 29(24): 7667-7678.
  • 6Nave KA, Salzer JL. Axonal regulation of myelination by neuregulin 1. Curt Opin Neurobiol, 2006, 16(5): 492-500.
  • 7Taveggia C, Zanazzi G, Petrylak A, et al. Neuregulin-1 type Ⅲ determines the ensheathment fate of axons. Neuron, 2005, 47 (5) : 6814594.
  • 8Sardi SP, Murtie J, Koirala S, et al. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell, 2006, 127( 1 ) : 185-197.
  • 9Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci, 2008, 9 (6): 437-452.
  • 10Hancock ML, Canetta SE, Role LW, et al. Presynaptic type Ⅲ neuregulinl -ErbB signaling targets (alpha) 7 nicotinic acetylcholine receptors to axons. J Cell Biol, 2008, 181 (3) : 511 - 521.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部